![]() | American Society for Cytotechnology |
Mission StatementThe American Society for Cytotechnology (ASCT) is a collective voice for the profession and is committed to defining and promoting the profession of cytotechnology. The organization:
HistoryThe American Society for Cytotechnology (ASCT) was founded in 1979 by nine dedicated individuals who passionately believed that cytotechnologists needed a national organization in which they could fully participate and shape their profession. The nine founding members were: Patricia R. Ashton, Elsie Carruthers, Catherine M. Keebler, Shirley E. Greening, Angela L. Savino, Margaret J. Harris, Florence Woodworth Patten, Edna Pixley, Marion Danos Holmquist. With the support of other active cytotechnologists, they established the American Society for Cytotechnology (ASCT). The ASCT became the first and only organization whose executive board is comprised solely of cytotechnologists. As is still true today, the ASCT provided a venue for discussion and collaboration on issues that uniquely affect cytotechnologists. The purposes of ASCT listed in the original articles of incorporation included:
From the outset, ASCT took a lead role in developing professional standards for cytotechnology and monitoring and responding to legislative and regulatory issues that impacted cytotechnologists. The legislative spotlight in the very first ASCT Newsletter (subsequently renamed ASCT News after the fourth issue, and then ASCT Voice in 2004) focused on the Personnel Standards for the Clinical Laboratory that were proposed in the Federal Register at the time. ASCT’s Professional Standards and Practices Committee developed and introduced a proposal for workload recommendations even prior to the 1987 Wall Street Journal article that highlighted the problem with workload at the time, "Lax Laboratories: The Pap Test Misses Much Cervical Cancer Through Labs’ Errors." Following the passage of CLIA ’88, ASCT was at the forefront in responding to the Health Care Financing Administration’s (HCFA) Notice of Proposed Rulemaking . Representatives from the ASCT spoke before Congressional committees and subcommittees on behalf of the cytotechnology community. In 1989, ASCT was awarded the HCFA contract to survey Cytology laboratories for compliance with the new Federal Laboratory Regulations. A new subsidiary of the ASCT, called ASCT Services Inc., was created to manage this contract. ASCT Services remains the sole owner of this contract, which is now overseen by the Center for Medicare and Medicaid Services (CMS). ASCT was born out of a need for an organization that focused specifically on cytotechnology. As part of ASCT’s 25th anniversary celebration at the 2004 Annual Conference, founding member Florence Woodworth Patten described the formation of ASCT in her keynote address, A Need-An Idea-the ASCT, as "a fairly tumultuous labor accompanying its delivery, an infancy and adolescence that have led to a strong and productive organization". Thirty years after its founding, ASCT still focuses on bringing cytotechnologists’ needs and ideas to the forefront in their ever changing work environment. ASCT Bylaws - Revised January 2025.pdfASCT Code of Conduct Policy - Updated 1.16.25.pdf |